Skip to main content

Day: February 3, 2022

Nexstim Reaches Over 300 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry

Press release, Helsinki, 3 February 2022 at 3:15 PM (EET) Nexstim Reaches Over 300 Completed Treatment Sessions – Continues to Report a Remission Rate Greater than 50% of MDD Patients in the Patient Registry Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) reports clinical outcomes of the 311 patients who have completed Nexstim SmartFocus® rTMS treatment with Nexstim NBT® system for major depressive disorder (MDD). Nexstim NBT® system is indicated for the treatment of MDD in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Treatment outcomes of these 311 patients were very good: 50.2% were in remission at end of treatment and 76.5% had obtained a clinical response. These outcomes are clearly higher than what is usually reported...

Continue reading

Better Choice Company Announces Phillips Pet Food & Supplies as a National Distribution Partner For Halo Elevate, Unlocking Additional 500+ Independent Pet Stores in 2022

NEW YORK, Feb. 03, 2022 (GLOBE NEWSWIRE) — Better Choice Company (NYSE American: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it has reached a national distribution agreement with Phillips Pet Food & Supplies, one of the largest pet food distributors in the United States, to launch Halo Elevate. Together, Phillips Pet Food & Supplies and Better Choice anticipate that Halo Elevate will be available in more than 500 independent pet food stores, with first ship dates as early as March 2022. “We are incredibly excited to partner with Phillips for the national launch of Halo Elevate, our new ground-breaking brand of super premium, natural pet food. Phillip’s commitment to delivering high quality pet food and products across their extensive distribution...

Continue reading

Cerberus Sentinel Names President to Leadership Team

U.S. cybersecurity services firm promotes experienced executive SCOTTSDALE, Ariz., Feb. 03, 2022 (GLOBE NEWSWIRE) — Cerberus Cyber Sentinel Corporation (NASDAQ: CISO), a Managed Compliance and Cybersecurity Provider (MCCP) based in Scottsdale, Ariz., announces that Rory Sanchez has been named president of the company. He will be responsible for mergers and acquisitions and work closely with CEO David Jemmett and CFO Deb Smith. Previously, Sanchez served as CEO of True Digital Security, a cybersecurity operations and compliance company with offices in New York, Florida, and Oklahoma. The company was recently acquired by Cerberus Sentinel. “With our acquisition and organic growth model, having a president with Rory’s experience in M&A transactions is critical to our future success,” said David Jemmett, CEO, Cerberus Sentinel....

Continue reading

BIO-key to Significantly Expand Customer Reach and Talent in EMEA Region via Definitive Agreement to Acquire Authentication Solutions Provider Swivel Secure Europe

WALL, N.J., Feb. 03, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced that it has signed a definitive agreement to acquire Swivel Secure Europe, S.A (SSE), a privately-held IAM solutions provider based in Madrid, Spain serving the European, Middle East and African (EMEA) markets. The transaction is expected to close in February and be accretive to BIO-key’s earnings, excluding one-time acquisition-related costs and ongoing purchase accounting amortization expenses. On a preliminary unaudited basis, SSE generated over $3.1M in revenue and $578K in operating income in fiscal/calendar 2021. As a result of the acquisition, BIO-key will add a sales and support team with...

Continue reading

Duolingo to Announce Fourth Quarter and Full Year 2021 Results on Thursday, March 3, 2022

PITTSBURGH, Feb. 03, 2022 (GLOBE NEWSWIRE) — Duolingo, Inc. (Nasdaq: DUOL), the world’s leading mobile language learning platform, will announce its results for the fourth quarter and full year ending December 31, 2021, following the close of the U.S. market on Thursday, March 3, 2022. The Company will host a corresponding conference call and webcast at 5:30 p.m. Eastern time on that day. A live webcast of the earnings call will be accessible to the public at https://investors.duolingo.com. A webcast replay will be available after the live event. About DuolingoDuolingo is the leading mobile learning platform globally, offering courses in 40 languages to approximately 40 million monthly active users. With over 500 million downloads, its flagship app has organically become the world’s most popular way to learn languages...

Continue reading

Catalyst Pharmaceuticals Reports that the FDA Marketing Approval Previously Granted for Ruzurgi® is No Longer Valid

Earlier this Week the District Court Granted Summary Judgement to Catalyst in Its Lawsuit Against the FDA and this FDA Action is the Result of that Decision CORAL GABLES, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare diseases, today reported that the District Court which heard Catalyst’s Lawsuit against the FDA has entered summary judgment in favor of Catalyst. The District Court’s order implements the prior decision of the U.S. Court of Appeals for the 11th Circuit, which ruled that the United States Food and Drug Administration’s (“FDA”) approval of Ruzurgi®...

Continue reading

Grano´s sale of the SokoPro business expected to be completed in February 2022

Panostaja Oyj          Stock Exchange Bulletin        February 3, 2022        15:00 pm.         Grano´s sale of the SokoPro business expected to be completed in February 2022 The sale of the SokoPro business owned by Panostaja’s Grano segment in accordance with the stock exchange release published on 23 December 2021, is expected to be completed in February 2022. It was previously announced that the transaction would be expected to be completed by the end of January 2022. Panostaja Oyj Tapio TommilaCEOMore information: Tapio Tommila, CEO, Panostaja Oyj, +358 (0)40 527 6311, tapio.tommila@panostaja.fiPanostaja is an investment company developing Finnish companies in the service and software sectors as an active shareholder. The company aims to be the most sought-after partner for business owners selling their companies as well as for...

Continue reading

Municipality Finance’s capital adequacy remains well above the ECB minimum requirements

Municipality Finance PlcStock Exchange Release3 February 2022 at 3:00 pm (EET) Municipality Finance’s capital adequacy remains well above the ECB minimum requirements The European Central Bank has updated the capital buffer requirement (P2R) imposed on Municipality Finance Plc (MuniFin) as part of the yearly Supervisory Review and Evaluation Process (SREP). The updated P2R is 2 percent, which is 0.25 percentage points lower than previously. The updated P2R will enter into force on 1 March 2022. When taking into account the P2R, the total SREP capital requirement (TSCR) ratio is currently 10 percent. The minimum level of total capital ratio including P2R and other capital buffer requirements is 13.15 percent as of 1 March 2022. MuniFin’s capital adequacy ratio exceeds the requirement by multiple times. At the end of June 2021, the Group’s...

Continue reading

scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

BURLINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17 at 4:20pm EDT. A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com. About scPharmaceuticals scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops,...

Continue reading

Piezo Motion Announces a Partnership to Expand Its Disruptive Precision Motor Technology

Piezo Motion’s partnership with Applied Mechatronics will deliver affordable micro-precision motors and motion control solutions to the West Coast LAKEWOOD RANCH, Fla., Feb. 03, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Piezo Motion, a Brain Scientific (OTCQB:BRSF) company, and Applied Mechatronics today announce a partnership. Piezo Motion is a developer and leading manufacturer of automation technology. Applied Mechatronics, based in Walnut Creek, California, has been a manufacturing representative in the motion control industry since 2002. Applied Mechatronics’ primary focus is on applications and manufacturers in Washington, Oregon, California and Nevada that serve mechanical and electronic automation. Piezo Motion’s multifaceted rotary and linear motors are built with technology that provides a stable, accurate motor...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.